Green Cross Corporation (006280) - Financial and Strategic SWOT Analysis Review

Date: July 5, 2016
Pages: 43
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: G2FB96F180EEN
Leaflet:

Download PDF Leaflet

Green Cross Corporation (006280) - Financial and Strategic SWOT Analysis Review
Green Cross Corporation (006280) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Green Cross Corporation (Green Cross) is a pharmaceutical company that researches, develops, produces and markets a range of prescription and over the counter pharmaceuticals. It offers prescription drugs, which including blood derivatives; vaccines; recombinant fibrinolytic agents and herbal medicine. These products are indicated for the treatment of various disorders including immune deficiency diseases, blood coagulation and albumin loss; hunter syndrome; cerebral infraction and thrombolic disorders. Its over the counter drugs include anti-inflammatory drugs, anti-allergic creams and herbal cataplasma patches for relief from bruises and muscle aches, among others. It offers its products under various brands namely, Hunterase; Shinbaro; GreenGene; GC FLU; Acustop and Kenhancer among others. The company distributes its products through a network of distribution channels. Green Cross is headquartered in Yongin, Korea.

Green Cross Corporation Key Recent Developments

May 31, 2016: Marken And Green Cross LabCell Sign MOU
Mar 09, 2015: Green Cross Expands Cell Therapy Business in China

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Green Cross Corporation - Key Facts
Green Cross Corporation - Key Employees
Green Cross Corporation - Key Employee Biographies
Green Cross Corporation - Major Products and Services
Green Cross Corporation - Pharmaceutical Pipeline Products Data
Green Cross Corporation, Pipeline Products by Therapy Area
Green Cross Corporation, Pipeline Products by Development Phase
Green Cross Corporation - History
Green Cross Corporation - Company Statement
Green Cross Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Green Cross Corporation - Business Description
Green Cross Corporation - Corporate Strategy
Green Cross Corporation - SWOT Analysis
SWOT Analysis - Overview
Green Cross Corporation - Strengths
Strength - Focus on Research and Development Activities
Strength - Increase in Sale of Pharmaceutical Products
Strength - Market Leadership
Green Cross Corporation - Weaknesses
Weakness - Declining Revenue from Overseas Market
Green Cross Corporation - Opportunities
Opportunity - Promising Product Pipeline
Opportunity - Product Approval
Opportunity - Strategic Initiatives
Green Cross Corporation - Threats
Threat - Competitive Pressures
Threat - Stringent Government Regulations
Threat - Rapid Technological Advancements
Green Cross Corporation - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Green Cross Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Green Cross Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Green Cross Corporation, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

May 31, 2016: Marken And Green Cross LabCell Sign MOU
Mar 09, 2015: Green Cross Expands Cell Therapy Business in China

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Green Cross Corporation, Key Facts
Green Cross Corporation, Key Employees
Green Cross Corporation, Key Employee Biographies
Green Cross Corporation, Major Products and Services
Green Cross Corporation, Number of Pipeline Products by Therapy Area
Green Cross Corporation, Number of Pipeline Products by Development Stage
Green Cross Corporation, Pipeline Products By Therapy Area and Development Phase
Green Cross Corporation, History
Green Cross Corporation, Other Locations
Green Cross Corporation, Subsidiaries
Green Cross Corporation, Key Competitors
Green Cross Corporation, Ratios based on current share price
Green Cross Corporation, Annual Ratios
Green Cross Corporation, Interim Ratios
Green Cross Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Green Cross Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Green Cross Corporation, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Green Cross Corporation, Pipeline Products by Therapy Area
Green Cross Corporation, Pipeline Products by Development Phase
Green Cross Corporation, Performance Chart (2011 - 2015)
Green Cross Corporation, Ratio Charts
Green Cross Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Green Cross Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
Skip to top


Ask Your Question

Green Cross Corporation (006280) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: